Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.

Saved in:
Bibliographic Details
Title: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
Authors: Strojnik K; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Blatnik A; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; University of Ljubljana, Ljubljana, Slovenia., Krajc M; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; University of Ljubljana, Ljubljana, Slovenia., Novaković A; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Ignjatović M; Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Ocvirk J; Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Stegel V; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Škerl P; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Klančar G; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Novaković S; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Šetrajčič Dragoš V; University of Ljubljana, Ljubljana, Slovenia. vsetrajcic@onko-i.si.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. vsetrajcic@onko-i.si.
Source: BJC reports [BJC Rep] 2026 Feb 16; Vol. 4 (1), pp. 5. Date of Electronic Publication: 2026 Feb 16.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918752188106676 Publication Model: Electronic Cited Medium: Internet ISSN: 2731-9377 (Electronic) Linking ISSN: 27319377 NLM ISO Abbreviation: BJC Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first